Connect With a Licensed Provider If needed, youll meet with a licensed provider through a virtual visit
Efficacy and safety of tirzepatide in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized phase II/III trials
Long-acting injectable semaglutide microcapsules were quantified by HPLC using a system containing a C8 column and a mixture of acetonitrile, water, and 0.1% trifluoroacetic acid [69]
This is a phase 3, multicenter, randomized, placebo-controlled, double- blinded clinical trial investigating the efficacy and safety of maximum tolerated dose (MTD) of tirzepatide (10 mg or 15 mg) administered once weekly (QW) subcutaneously compared with placebo for body weight management, in participants who have obesity, or overweight with at least 1 obesity-related complication (excluding type 2 diabetes), and with at least 5% weight reduction following a 12-week intensive lifestyle intervention lead-in
As the best GLP-1 app available, it gives you insights that generic trackers simply can't provide
Results from the landmark SELECT trial showed that weekly semaglutide lowered the risk of heart attack, stroke, or cardiovascular death by 20 percent in adults with overweight or obesity and established cardiovascular disease
